Clinical Trial Update: A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 study of a respiratory combination vaccine targeting respiratory syncytial virus and influenza in healthy older adults; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Pfizer RSV and influenza combination vaccine

Snippet

Sponsor: Pfizer | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2024-11-22